131 related articles for article (PubMed ID: 31620234)
1. Deuteration of BTZ043 Extends the Lifetime of Meisenheimer Intermediates to the Antituberculosis Nitroso Oxidation State.
Liu R; Krchnak V; Brown SN; Miller MJ
ACS Med Chem Lett; 2019 Oct; 10(10):1462-1466. PubMed ID: 31620234
[TBL] [Abstract][Full Text] [Related]
2. Thiolates chemically induce redox activation of BTZ043 and related potent nitroaromatic anti-tuberculosis agents.
Tiwari R; Moraski GC; Krchňák V; Miller PA; Colon-Martinez M; Herrero E; Oliver AG; Miller MJ
J Am Chem Soc; 2013 Mar; 135(9):3539-49. PubMed ID: 23402278
[TBL] [Abstract][Full Text] [Related]
3. Benzothiazinones: prodrugs that covalently modify the decaprenylphosphoryl-β-D-ribose 2'-epimerase DprE1 of Mycobacterium tuberculosis.
Trefzer C; Rengifo-Gonzalez M; Hinner MJ; Schneider P; Makarov V; Cole ST; Johnsson K
J Am Chem Soc; 2010 Oct; 132(39):13663-5. PubMed ID: 20828197
[TBL] [Abstract][Full Text] [Related]
4. In Vivo Dearomatization of the Potent Antituberculosis Agent BTZ043 via Meisenheimer Complex Formation.
Kloss F; Krchnak V; Krchnakova A; Schieferdecker S; Dreisbach J; Krone V; Möllmann U; Hoelscher M; Miller MJ
Angew Chem Int Ed Engl; 2017 Feb; 56(8):2187-2191. PubMed ID: 28097740
[TBL] [Abstract][Full Text] [Related]
5. Design, synthesis and evaluation of covalent inhibitors of DprE1 as antitubercular agents.
Liu L; Kong C; Fumagalli M; Savková K; Xu Y; Huszár S; Sammartino JC; Fan D; Chiarelli LR; Mikušová K; Sun Z; Qiao C
Eur J Med Chem; 2020 Dec; 208():112773. PubMed ID: 32898793
[TBL] [Abstract][Full Text] [Related]
6. Benzothiazinones are suicide inhibitors of mycobacterial decaprenylphosphoryl-β-D-ribofuranose 2'-oxidase DprE1.
Trefzer C; Škovierová H; Buroni S; Bobovská A; Nenci S; Molteni E; Pojer F; Pasca MR; Makarov V; Cole ST; Riccardi G; Mikušová K; Johnsson K
J Am Chem Soc; 2012 Jan; 134(2):912-5. PubMed ID: 22188377
[TBL] [Abstract][Full Text] [Related]
7. BTZ-Derived Benzisothiazolinones with In Vitro Activity against
Richter A; Seidel RW; Goddard R; Eckhardt T; Lehmann C; Dörner J; Siersleben F; Sondermann T; Mann L; Patzer M; Jäger C; Reiling N; Imming P
ACS Med Chem Lett; 2022 Aug; 13(8):1302-1310. PubMed ID: 35982823
[TBL] [Abstract][Full Text] [Related]
8. Syntheses and Antituberculosis Activity of 1,3-Benzothiazinone Sulfoxide and Sulfone Derived from BTZ043.
Tiwari R; Miller PA; Cho S; Franzblau SG; Miller MJ
ACS Med Chem Lett; 2015 Feb; 6(2):128-33. PubMed ID: 25699139
[TBL] [Abstract][Full Text] [Related]
9. Characterization of DprE1-Mediated Benzothiazinone Resistance in Mycobacterium tuberculosis.
Foo CS; Lechartier B; Kolly GS; Boy-Röttger S; Neres J; Rybniker J; Lupien A; Sala C; Piton J; Cole ST
Antimicrob Agents Chemother; 2016 Nov; 60(11):6451-6459. PubMed ID: 27527085
[TBL] [Abstract][Full Text] [Related]
10. Design and Syntheses of Anti-Tuberculosis Agents Inspired by BTZ043 Using a Scaffold Simplification Strategy.
Tiwari R; Möllmann U; Cho S; Franzblau SG; Miller PA; Miller MJ
ACS Med Chem Lett; 2014 May; 5(5):587-91. PubMed ID: 24900885
[TBL] [Abstract][Full Text] [Related]
11. Novel insight into the reaction of nitro, nitroso and hydroxylamino benzothiazinones and of benzoxacinones with Mycobacterium tuberculosis DprE1.
Richter A; Rudolph I; Möllmann U; Voigt K; Chung CW; Singh OMP; Rees M; Mendoza-Losana A; Bates R; Ballell L; Batt S; Veerapen N; Fütterer K; Besra G; Imming P; Argyrou A
Sci Rep; 2018 Sep; 8(1):13473. PubMed ID: 30194385
[TBL] [Abstract][Full Text] [Related]
12. Synthesis, structural characterization and antimycobacterial evaluation of several halogenated non-nitro benzothiazinones.
Madikizela B; Eckhardt T; Goddard R; Richter A; Lins A; Lehmann C; Imming P; Seidel RW
Med Chem Res; 2021; 30(8):1523-1533. PubMed ID: 34131377
[TBL] [Abstract][Full Text] [Related]
13. Design, Syntheses, and Anti-TB Activity of 1,3-Benzothiazinone Azide and Click Chemistry Products Inspired by BTZ043.
Tiwari R; Miller PA; Chiarelli LR; Mori G; Šarkan M; Centárová I; Cho S; Mikušová K; Franzblau SG; Oliver AG; Miller MJ
ACS Med Chem Lett; 2016 Mar; 7(3):266-70. PubMed ID: 26985313
[TBL] [Abstract][Full Text] [Related]
14. The 8-Pyrrole-Benzothiazinones Are Noncovalent Inhibitors of DprE1 from Mycobacterium tuberculosis.
Makarov V; Neres J; Hartkoorn RC; Ryabova OB; Kazakova E; Šarkan M; Huszár S; Piton J; Kolly GS; Vocat A; Conroy TM; Mikušová K; Cole ST
Antimicrob Agents Chemother; 2015 Aug; 59(8):4446-52. PubMed ID: 25987616
[TBL] [Abstract][Full Text] [Related]
15. Structure, dynamics, and interaction of Mycobacterium tuberculosis (Mtb) DprE1 and DprE2 examined by molecular modeling, simulation, and electrostatic studies.
Bhutani I; Loharch S; Gupta P; Madathil R; Parkesh R
PLoS One; 2015; 10(3):e0119771. PubMed ID: 25789990
[TBL] [Abstract][Full Text] [Related]
16. Whole cell hydride Meisenheimer complex biotransformation guided optimization of antimycobacterial benzothiazinones.
Joch M; Wojtas KP; Torres-Gómez H; Li Y; Meyer F; Straßburger M; Kerndl V; Dahse HM; Hertweck C; Hoffmann H; Görls H; Walter K; Hölscher C; Kloss F
Eur J Med Chem; 2024 Jan; 264():116023. PubMed ID: 38071794
[TBL] [Abstract][Full Text] [Related]
17. Hydride-induced Meisenheimer complex formation reflects activity of nitro aromatic anti-tuberculosis compounds.
Liu R; Markley L; Miller PA; Franzblau S; Shetye G; Ma R; Savková K; Mikušová K; Lee BS; Pethe K; Moraski GC; Miller MJ
RSC Med Chem; 2021 Jan; 12(1):62-72. PubMed ID: 34046598
[TBL] [Abstract][Full Text] [Related]
18. Biodegradation of nitroaromatic compounds.
Spain JC
Annu Rev Microbiol; 1995; 49():523-55. PubMed ID: 8561470
[TBL] [Abstract][Full Text] [Related]
19. Biological and structural characterization of the Mycobacterium smegmatis nitroreductase NfnB, and its role in benzothiazinone resistance.
Manina G; Bellinzoni M; Pasca MR; Neres J; Milano A; Ribeiro AL; Buroni S; Skovierová H; Dianišková P; Mikušová K; Marák J; Makarov V; Giganti D; Haouz A; Lucarelli AP; Degiacomi G; Piazza A; Chiarelli LR; De Rossi E; Salina E; Cole ST; Alzari PM; Riccardi G
Mol Microbiol; 2010 Sep; 77(5):1172-85. PubMed ID: 20624223
[TBL] [Abstract][Full Text] [Related]
20. Development of 6-Methanesulfonyl-8-nitrobenzothiazinone Based Antitubercular Agents.
Shi R; Wang B; Stelitano G; Wu X; Shan Y; Wu Y; Wang X; Chiarelli LR; Lu Y; Qiao C
ACS Med Chem Lett; 2022 Apr; 13(4):593-598. PubMed ID: 35450361
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
